Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
24.59
+0.11 (0.45%)
Jul 3, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Biopharmaceutical and Diagnostic Solutions | 933.74M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical and Diagnostic Solutions Growth | 8.27% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Engineering | 170.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Engineering Growth | -15.80% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Other | 6.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 277.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical and Diagnostic Solutions Operating Profit | 165.64M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical and Diagnostic Solutions Operating Profit Growth | 1.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Engineering Operating Profit | 33.10M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Engineering Operating Profit Growth | -29.51% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Operating Profit | -37.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Operating Profit Growth | 9.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 6.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 277.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 6.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 277.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Gross Income by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Other | 3.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 3.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical and Diagnostic Solutions Gross Profit | 268.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Biopharmaceutical and Diagnostic Solutions Gross Profit Growth | 28.08% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Engineering Gross Profit | 56.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Engineering Gross Profit Growth | -37.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Gross Profit | -22.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Eliminations from Gross Profit Growth | 46.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 3.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
EMEA | 667.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EMEA Growth | 9.15% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC | 96.24M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
APAC Growth | 1.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America | 308.95M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
North America Growth | -4.55% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South America | 31.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South America Growth | -6.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Backlog | 853.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Backlog Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|